Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis.
Saved in:
| Title: | Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis. |
|---|---|
| Authors: | Johnsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: magnus.johnsson@neuro.gu.se., Lycke J; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Novakova L; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Rosenstein I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Hafsteinsdottir B; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden., Malmeström C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Laboratory for Clinical Immunology, Clinical immunology and transfusion medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Axelsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. |
| Source: | Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2026 May; Vol. 109, pp. 107163. Date of Electronic Publication: 2026 Mar 26. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41926864 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Johnsson+M%22">Johnsson M</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: magnus.johnsson@neuro.gu.se.<br /><searchLink fieldCode="AU" term="%22Lycke+J%22">Lycke J</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Novakova+L%22">Novakova L</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Rosenstein+I%22">Rosenstein I</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Hafsteinsdottir+B%22">Hafsteinsdottir B</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Malmeström+C%22">Malmeström C</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Laboratory for Clinical Immunology, Clinical immunology and transfusion medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Axelsson+M%22">Axelsson M</searchLink>; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Neurology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101580247%22">Multiple sclerosis and related disorders</searchLink> [Mult Scler Relat Disord] 2026 May; Vol. 109, pp. 107163. <i>Date of Electronic Publication: </i>2026 Mar 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2E+V%22">Elsevier B. V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101580247 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-0356 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222110348%22">22110348 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler Relat Disord <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41926864 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.msard.2026.107163 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107163 Titles: – TitleFull: Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Johnsson M – PersonEntity: Name: NameFull: Lycke J – PersonEntity: Name: NameFull: Novakova L – PersonEntity: Name: NameFull: Rosenstein I – PersonEntity: Name: NameFull: Hafsteinsdottir B – PersonEntity: Name: NameFull: Malmeström C – PersonEntity: Name: NameFull: Axelsson M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2211-0356 Numbering: – Type: volume Value: 109 Titles: – TitleFull: Multiple sclerosis and related disorders Type: main |
| ResultId | 1 |
